To determine the role of ITGAV in HCC progression, we evaluated ITGAV expression levels in HCC samples in The Cancer Genome Atlas (TCGA, https://cancergenome.nih.gov/, accessed on 7 February 2022) database. Here, ITGAV is linked to hepatocellular carcinoma.